Welcome to LookChem.com Sign In|Join Free
  • or
2,6-Piperidinedimethanol, 1-(phenylmethyl)-, (2R,6S)-rel- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

128580-93-8

Post Buying Request

128580-93-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128580-93-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 128580-93-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,5,8 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 128580-93:
(8*1)+(7*2)+(6*8)+(5*5)+(4*8)+(3*0)+(2*9)+(1*3)=148
148 % 10 = 8
So 128580-93-8 is a valid CAS Registry Number.

128580-93-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-benzyl-cis-2,6-bis(hydroxymethyl)piperidine

1.2 Other means of identification

Product number -
Other names ((2S,6R)-1-Benzyl-6-hydroxymethyl-piperidin-2-yl)-methanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:128580-93-8 SDS

128580-93-8Relevant academic research and scientific papers

Synthesis of DTPA analogues derived from piperidine and azepane: Potential contrast enhancement agents for magnetic resonance imaging

Chong,Garmestani,Bryant Jr.,Brechbiel

, p. 7745 - 7750 (2007/10/03)

Two DTPA derivatives (PIP-DTPA and AZEP-DTPA) as potential contrast enhancement agents in MRI are synthesized. The T1 and T2 relaxivities of their corresponding Gd(III) complexes are reported. At clinically relevant field strengths, the relaxivities of the complexes are comparable to that of the contrast agent, Gd(DTPA) which is in clinical use. The serum stability of the 153Gd-labeled complexes is assessed by measuring the release of 153Gd from the ligands. The radiolabeled Gd chelates are found to be kinetically stable in human serum for up to at least 14 days without any measurable loss of radioactivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 128580-93-8